A detailed history of Aspiriant, LLC transactions in Technology Sector Spdr stock. As of the latest transaction made, Aspiriant, LLC holds 3,507 shares of XLK stock, worth $819,235. This represents 0.03% of its overall portfolio holdings.

Number of Shares
3,507
Previous 3,301 6.24%
Holding current value
$819,235
Previous $746,000 6.03%
% of portfolio
0.03%
Previous 0.03%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 17, 2024

BUY
$197.34 - $237.68 $40,652 - $48,962
206 Added 6.24%
3,507 $791,000
Q2 2024

Jul 15, 2024

BUY
$192.53 - $231.41 $69,503 - $83,539
361 Added 12.28%
3,301 $746,000
Q1 2024

Apr 15, 2024

BUY
$184.12 - $211.02 $48,423 - $55,498
263 Added 9.82%
2,940 $612,000
Q3 2023

Oct 17, 2023

BUY
$161.97 - $180.26 $58,795 - $65,434
363 Added 15.69%
2,677 $438,000
Q2 2023

Jul 19, 2023

SELL
$143.97 - $174.63 $14,397 - $17,463
-100 Reduced 4.14%
2,314 $402,000
Q1 2023

Apr 27, 2023

BUY
$121.18 - $151.01 $121 - $151
1 Added 0.04%
2,414 $364,000
Q4 2022

Jan 23, 2023

SELL
$116.56 - $136.15 $90,800 - $106,060
-779 Reduced 24.4%
2,413 $0
Q3 2022

Oct 28, 2022

SELL
$118.78 - $151.56 $1,781 - $2,273
-15 Reduced 0.47%
3,192 $379,000
Q2 2022

Jul 25, 2022

SELL
$123.49 - $161.47 $82,738 - $108,184
-670 Reduced 17.28%
3,207 $407,000
Q1 2022

May 06, 2022

BUY
$141.39 - $175.52 $102,224 - $126,900
723 Added 22.92%
3,877 $615,000
Q4 2021

Feb 14, 2022

SELL
$148.06 - $176.65 $14,213 - $16,958
-96 Reduced 2.95%
3,154 $548,000
Q1 2021

May 11, 2021

BUY
$125.83 - $138.59 $114,127 - $125,701
907 Added 38.71%
3,250 $431,000
Q3 2020

Oct 29, 2020

BUY
$104.66 - $127.03 $245,218 - $297,631
2,343 New
2,343 $273,000

Others Institutions Holding XLK

About TECHNOLOGY SECTOR SPDR


  • Ticker XLK
  • Sector ETFs
  • Industry ETFs
More about XLK
Track This Portfolio

Track Aspiriant, LLC Portfolio

Follow Aspiriant, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Aspiriant, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Aspiriant, LLC with notifications on news.